90 related articles for article (PubMed ID: 2657866)
61. Pharmacokinetics of nocloprost in human volunteers and its relation to dose.
Tüber U; Brudny-Klöppel M; Jakobs U; Madetzki C; Mahler M
Eur J Clin Pharmacol; 1993; 44(5):497-500. PubMed ID: 8359191
[TBL] [Abstract][Full Text] [Related]
62. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
[TBL] [Abstract][Full Text] [Related]
63. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
Brunner F; Kolmayr U; Kukovetz WR
Arzneimittelforschung; 1989 Nov; 39(11):1430-5. PubMed ID: 2619776
[TBL] [Abstract][Full Text] [Related]
64. Characterization of oral sustained release preparations of iloprost in a pig model by plasma level monitoring.
Hildebrand H; McDonald FM; Windt-Hanke F
Prostaglandins; 1991 May; 41(5):473-86. PubMed ID: 1713701
[TBL] [Abstract][Full Text] [Related]
65. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
[TBL] [Abstract][Full Text] [Related]
66. Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers.
Tse FL; Jaffe JM; Troendle A
J Clin Pharmacol; 1992 Jul; 32(7):630-8. PubMed ID: 1640002
[TBL] [Abstract][Full Text] [Related]
67. Pharmacokinetics of spironolactone in man.
Abshagen U; Rennekamp H; Luszpinski G
Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):37-45. PubMed ID: 1012347
[TBL] [Abstract][Full Text] [Related]
68. Absorption, metabolism, and excretion of intravenously and orally administered [14C]telmisartan in healthy volunteers.
Stangier J; Schmid J; Türck D; Switek H; Verhagen A; Peeters PA; van Marle SP; Tamminga WJ; Sollie FA; Jonkman JH
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1312-22. PubMed ID: 11185629
[TBL] [Abstract][Full Text] [Related]
69. Dy-EOB-DTPA: tolerance and pharmacokinetics in healthy volunteers and preliminary liver imaging in patients.
Krause W; Mahler M; Hanke B; Milius W; Kaufmann J; Rogalla P; Hamm B
Invest Radiol; 2001 Aug; 36(8):431-44. PubMed ID: 11500593
[TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
[TBL] [Abstract][Full Text] [Related]
71. The metabolic fate of 3[H]econazole in man.
Midgley I; van Bladeren PJ; Hawkins DR; Chasseaud LF; Darragh A; Brodie RR; Walmsley LM
Xenobiotica; 1981 Sep; 11(9):595-608. PubMed ID: 7314642
[TBL] [Abstract][Full Text] [Related]
72. Pharmacokinetics and pharmacodynamics of the stable prostacyclin analogue, ZK 36 374, in the cat.
Krause W; Beckmann R; Schubert M
Prostaglandins Leukot Med; 1984 Aug; 15(2):187-97. PubMed ID: 6208562
[TBL] [Abstract][Full Text] [Related]
73. Pharmacokinetics of eltoprazine in healthy subjects.
van Harten J; Mathlener IS; Raghoebar M
Drug Metabol Drug Interact; 1990; 8(1-2):149-58. PubMed ID: 2091888
[TBL] [Abstract][Full Text] [Related]
74. Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability.
Bernstein LR; Tanner T; Godfrey C; Noll B
Met Based Drugs; 2000; 7(1):33-47. PubMed ID: 18475921
[TBL] [Abstract][Full Text] [Related]
75. Lipid analogues as potential drugs for the regulation of mitochondrial cell death.
Murray M; Dyari HR; Allison SE; Rawling T
Br J Pharmacol; 2014 Apr; 171(8):2051-66. PubMed ID: 24111728
[TBL] [Abstract][Full Text] [Related]
76. Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.
Belch JJ; McLaren M; Lau CS; Mackay IR; Bancroft A; McEwen J; Thompson JM
Br J Clin Pharmacol; 1993 Jun; 35(6):643-7. PubMed ID: 8329292
[TBL] [Abstract][Full Text] [Related]
77. Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 micrograms.
Hildebrand M; Staks T; Nieuweboer B
Eur J Clin Pharmacol; 1990; 39(2):149-53. PubMed ID: 2253664
[TBL] [Abstract][Full Text] [Related]
78. Pharmacokinetics of 3H-cicaprost in healthy volunteers.
Hildebrand M; Staks T; Schütt A; Matthes H
Prostaglandins; 1989 Feb; 37(2):259-73. PubMed ID: 2657866
[TBL] [Abstract][Full Text] [Related]
79. Studies on the pharmacokinetics of ZK 96 480, a novel PGI2-mimetic, in rat and cynomolgus monkey.
Hildebrand M
Prostaglandins; 1986 Sep; 32(3):425-38. PubMed ID: 3538205
[TBL] [Abstract][Full Text] [Related]
80. Pharmacokinetics of iloprost and cicaprost in mice.
Hildebrand M
Prostaglandins; 1992 Nov; 44(5):431-42. PubMed ID: 1281921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
